iSOFT Signs Sixth LORENZO Site in Germany

iSOFT Group LimitediSOFT Group Limited (ASX: ISF) - Australia's largest listed health information technology company today announced that Christophorus-Kliniken will become the sixth early adopter of iSOFT’s LORENZO next-generation solution in Germany as part of an agreement to upgrade hospital information systems (HIS) at its three hospitals in the Coesfeld district of North Rhine-Westphalia.

The five-year deal potentially is worth as much as €1.43 million (A$2.5 million). The initial two phases, which include the first LORENZO components and an upgrade of iSOFT's ClinicCentre HIS solution, are valued at €675,000 (A$1.2 million) in license fees and services plus €257,000 (A$447,000) in support and maintenance services over five years. An optional third phase, which includes additional LORENZO functionality, is worth a potential €500,000 (A$870,000).

"This is further evidence that our new LORENZO technology is gaining traction with our existing client base in Europe," said Gary Cohen, iSOFT's Executive Chairman & CEO. "It's part of our broader strategy for LORENZO outside of the UK's National Programme for Information Technology."

The first LORENZO elements and iSOFT's Collaboration Suite (iCS) will provide a new electronic patient record (EPR) for GP's to access hospital patient records using standard web browsers. iCS allows the secure exchange of patient information between care providers to improve collaboration between teams.

Christophorus-Kliniken follows Klinikum Saarbrücken, which recently became iSOFT's fifth LORENZO early adopter in Germany. The three Christophorus-Kliniken hospitals covered by the new contract are Coesfeld's St Vincenz Hospital, Franz Hospital at Dülmen and St Gerburgis Hospital at Nottuln, which provide a total of 620 beds and employ 1,500 staff.

Christophorus-Kliniken is an existing client for iSOFT's ClinicCentre and its LabCentre laboratory information system and BusinessCentre finance, administration and management solution.

Other LORENZO early adopters in Germany are Aachen, Leipzig, Krankenhaus Buchholz and Winsen, and Klinikum Saarbrücken.

Related news articles:

About iSOFT Group
iSOFT Group Limited (ASX: ISF) is the largest health information technology company listed on the Australian Securities Exchange, and among the world's biggest providers of advanced application solutions in modern healthcare economies.

iSOFT works with healthcare professionals to design and build software applications that answer all of the difficult questions posed by today's healthcare delivery challenges. Our solutions act as a catalyst for change, supporting free exchange of critical information across diverse care settings and participating organisations.

Today, more than 13,000 provider organisations in 38 countries use iSOFT's solutions to manage patient information and drive improvements in their core processes. The Group's sustainable development is delivered through careful planning, in-depth analysis of the market, and anticipation of our clients' evolving requirements. Our business is driven by the collective talent, experience and commitment of more than 4,600 specialists in 16 locations worldwide, including more than 2,300 technology and development professionals.

A global network of iSOFT subsidiaries, supported by an extensive partner network, provides substantial experience of national healthcare markets. As a result, we offer our clients comprehensive knowledge of local market requirements in terms of culture, language, working practices, regulation and organizational structure.

Most Popular Now

Open Medical Works with Moray's Dig…

Open Medical is working with the Digital Health & Care Innovation Centre’s Rural Centre of Excellence on a referral management plan, as part of a research and development scheme to...

Generative AI on Track to Shape the Futu…

Using advanced artificial intelligence (AI), researchers have developed a novel method to make drug development faster and more efficient. In a new paper, Xia Ning, lead author of the study and...

Personalized Breast Cancer Prevention No…

A new telemedicine service for personalised breast cancer prevention has launched at preventcancer.co.uk. It allows women aged 30 to 75 across the UK to understand their risk of developing breast...

New App may Help Caregivers of People Ge…

A new study by investigators from Mass General Brigham showed that a new app they created can help improve the quality of life for caregivers of patients undergoing bone marrow...

An App to Detect Heart Attacks and Strok…

A potentially lifesaving new smartphone app can help people determine if they are suffering heart attacks or strokes and should seek medical attention, a clinical study suggests. The ECHAS app (Emergency...

A Machine Learning Tool for Diagnosing, …

Scientists aiming to advance cancer diagnostics have developed a machine learning tool that is able to identify metabolism-related molecular profile differences between patients with colorectal cancer and healthy people. The analysis...

Fine-Tuned LLMs Boost Error Detection in…

A type of artificial intelligence (AI) called fine-tuned large language models (LLMs) greatly enhances error detection in radiology reports, according to a new study published in Radiology, a journal of...

DeepSeek-R1 Offers Promising Potential t…

A joint research team from The Hong Kong University of Science and Technology and The Hong Kong University of Science and Technology (Guangzhou) has published a perspective article in MedComm...

Deep Learning can Predict Lung Cancer Ri…

A deep learning model was able to predict future lung cancer risk from a single low-dose chest CT scan, according to new research published at the ATS 2025 International Conference...